Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM9A | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
mRNA | XDH | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-11 |
mRNA | IRF6 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-10 |
mRNA | TEX13B | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
mRNA | S100A9 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | GPR87 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-08 |
mRNA | C1orf74 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | CSTA | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
mRNA | LPCAT2 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
mRNA | AC006386.1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |